Things You Didn’t Know About SLT - Scorecard - MDSpire

Things You Didn’t Know About SLT

Experienced surgeons dispel myths about selective laser trabeculoplasty and provide pearls and practice insights.

  • By

  • Syril K. Dorairaj, MD, and

  • Ariana Levin, MD

  • Tony Realini, MD, MPH

  • Constance O. Okeke, MD, MSCE

  • Steven R. Sarkisian, Jr., MD

  • Christine Funke, MD

  • Lorraine M. Provencher, MD

  • Marlene R. Moster, MD

  • Shivani S. Kamat, MD

  • Sahar Bedrood, MD, PhD

  • Douglas J. Rhee, MD

  • Jacob W. Brubaker, MD

  • Kateki Vinod, MD

  • Lauren S. Blieden, MD

  • Mary Qiu, MD,

  • Samantha Goldburg, MD

  • John Berdahl, MD

  • March 1, 2026

  • 18 min

Share

Clinical Scorecard: Things You Didn’t Know About SLT

At a Glance

CategoryDetail
ConditionGlaucoma
Key MechanismsSelective laser trabeculoplasty (SLT) reduces intraocular pressure (IOP) and improves ocular surface health.
Target PopulationPatients with glaucoma, particularly those with primary open-angle glaucoma (POAG) and ocular hypertension (OHTN).
Care SettingOphthalmology clinics and surgical centers.

Key Highlights

  • SLT is effective as a first-line therapy compared to topical medications.
  • It can serve as a rescue therapy for ocular surface health.
  • Patient counseling is crucial for acceptance of SLT.
  • SLT can be beneficial in uveitic eyes with elevated IOP.
  • The recent FDA approval of the Voyager DSLT system expands treatment options.

Guideline-Based Recommendations

Diagnosis

  • Perform gonioscopy to confirm angle openness before SLT.

Management

  • Consider SLT as a primary strategy for medication reduction.
  • Use topical NSAIDs after SLT in POAG and topical steroids in uveitic eyes.

Monitoring & Follow-up

  • Assess IOP and ocular surface health post-SLT.

Risks

  • Potential for elevated IOP post-SLT requiring additional procedures.

Patient & Prescribing Data

Patients with glaucoma, especially treatment-naïve individuals.

SLT can achieve significant IOP reduction, often exceeding 50% in treatment-naïve eyes.

Clinical Best Practices

  • Explain SLT as 'light energy treatment' to improve patient receptiveness.
  • Shift patient discussions from pressure reduction to quality of life improvement.
  • Utilize SLT early in the treatment paradigm for better outcomes.

Related Resources & Content

Original Source(s)

Things You Didn’t Know About SLT

  • by Syril K. Dorairaj, MD, and, Ariana Levin, MD, Tony Realini, MD, MPH, Constance O. Okeke, MD, MSCE, Steven R. Sarkisian, Jr., MD, Christine Funke, MD, Lorraine M. Provencher, MD, Marlene R. Moster, MD, Shivani S. Kamat, MD, Sahar Bedrood, MD, PhD, Douglas J. Rhee, MD, Jacob W. Brubaker, MD, Kateki Vinod, MD, Lauren S. Blieden, MD, Mary Qiu, MD,, Samantha Goldburg, MD, John Berdahl, MD

  • March 1, 2026

Related Content

Integrating AI Into Everyday Eyecare Practice

How AI technologies are transforming diagnostics, imaging analysis, workflow efficiency, and patient management.

Diagnostic Burdens in High Myopia

How to Stay at the Forefront of Ophthalmology

Forty-four years in, Heaton Eye is still learning, but its foundation hasn't changed. "We believe in the technologies we offer, we prepare our team for success, and we let the outcomes do the rest."